© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#bladder cancer

Keytruda Improves Long-Term Survival for People With Bladder Cancer
Treating Cancer No Matter Where It Occurs
Bladder Cancer 101

New Targeted Antibody Treatment for Bladder Cancer Shows Promise

More than 40% of people treated with enfortumab vedotin experienced complete or partial remission.
Cancer cells and lymphocytes

Cancer Appears More Aggressive in People with HIV

HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.

Bavencio

Balversa

FDA Approves First FGFR Inhibitor for People with Advanced Bladder Cancer

Balversa led to tumor regression in about a third of patients with susceptible genetic mutations.
Generic image

Bladder Cancer Medications

Here’s a list of the approved drugs to treat bladder cancer. Click on any of the medications for more info on indications, dosing and...
Cancer treatment

Cancer Medications

Opdivo

Mental Health Linked to Higher Death Rates Among Those With Urological Cancers

Mental health care before cancer treatment is associated with higher death rates for those with kidney, prostate or bladder cancer.
Tecentriq (atezolizumab)

Tecentriq

Nektar Therapeutics headquarters in San Francisco

Novel Immunotherapy Combo Shrinks Bladder Tumors

NKTR-214 plus Opdivo as first-line therapy had an overall response rate of 48 percent.

Cancer Awareness Months and Days

T cells attack a cancer cell

What’s New in Treatment for Advanced Bladder Cancer?

A new area of research is examining the use of checkpoint inhibitors before surgery, a practice known as neoadjuvant therapy.

TICE

Imfinzi

FDA Updates Prescribing Information for Keytruda and Tecentriq

Requires use of diagnostic tests for PD-L1 levels in tumor tissue from bladder cancer patients.
Advertisement
Treatment News
Newsfeed